Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Argirò

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
International Journal of Cardiology|December 30, 2021
Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysisAlessia Argirò, Hannah Rosenblum, Jan Griffin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2026
Incidence, Timing and Clinical Significance of Adverse Immune Events after Gene Replacement Therapy: a Systematic Review and Meta-AnalysisNiccolò Maurizi, Enrico Ammirati, Elizabeth Silver, et al.
Drugs|June 13, 2022
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to BedsideChiara Palandri, Lorenzo Santini, Alessia Argirò, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 1, 2023
Stage-specific therapy for hypertrophic cardiomyopathyAlessia Argirò, Mattia Zampieri, Alberto Marchi, et al.
Circulation. Heart Failure|April 7, 2026
Incidence, Timing and Clinical Significance of Immune-Mediated Myocardial Injury and Myocarditis After Gene Replacement Therapy: A Systematic Review and Meta-AnalysisNiccolò Maurizi, Enrico Ammirati, Elizabeth Silver, et al.
Journal of Cardiovascular Electrophysiology|February 9, 2022
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry diseaseLuigi Tassetti, Carlo Fumagalli, Alessia Argirò, et al.
Frontiers in Pharmacology|April 25, 2024
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathyJames A Coleman, Ruben Doste, Matteo Beltrami, et al.
The American Journal of Cardiology|September 27, 2017
Six-Year Outcome of Subjects Without Overt Heart Disease With an Early Repolarization/J Wave Electrocardiographic PatternGaetano Antonio Lanza, Alessia Argirò, Roberto Mollo, et al.
International Journal of Cardiology|May 2, 2024
Screening for cardiac amyloidosis in patients with tenosynovial red flags: A collaboration between family medicine and cardiologyValentina Andrei, Alessia Argirò, Carlotta Mazzoni, et al.
Biomedicines|December 23, 2022
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic DiseaseFederico Perfetto, Mattia Zampieri, Giulia Bandini, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Cardiology|December 30, 2021
Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysisAlessia Argirò, Hannah Rosenblum, Jan Griffin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2026
Incidence, Timing and Clinical Significance of Adverse Immune Events after Gene Replacement Therapy: a Systematic Review and Meta-AnalysisNiccolò Maurizi, Enrico Ammirati, Elizabeth Silver, et al.
Drugs|June 13, 2022
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to BedsideChiara Palandri, Lorenzo Santini, Alessia Argirò, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 1, 2023
Stage-specific therapy for hypertrophic cardiomyopathyAlessia Argirò, Mattia Zampieri, Alberto Marchi, et al.
Circulation. Heart Failure|April 7, 2026
Incidence, Timing and Clinical Significance of Immune-Mediated Myocardial Injury and Myocarditis After Gene Replacement Therapy: A Systematic Review and Meta-AnalysisNiccolò Maurizi, Enrico Ammirati, Elizabeth Silver, et al.
Journal of Cardiovascular Electrophysiology|February 9, 2022
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry diseaseLuigi Tassetti, Carlo Fumagalli, Alessia Argirò, et al.
Frontiers in Pharmacology|April 25, 2024
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathyJames A Coleman, Ruben Doste, Matteo Beltrami, et al.
The American Journal of Cardiology|September 27, 2017
Six-Year Outcome of Subjects Without Overt Heart Disease With an Early Repolarization/J Wave Electrocardiographic PatternGaetano Antonio Lanza, Alessia Argirò, Roberto Mollo, et al.
International Journal of Cardiology|May 2, 2024
Screening for cardiac amyloidosis in patients with tenosynovial red flags: A collaboration between family medicine and cardiologyValentina Andrei, Alessia Argirò, Carlotta Mazzoni, et al.
Biomedicines|December 23, 2022
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic DiseaseFederico Perfetto, Mattia Zampieri, Giulia Bandini, et al.
Pageof 8